openQ
Charlottesville, VA and Paris, France – July 7, 2009 - openQ, a leading provider of technology and information solutions for the life sciences industry, announced today a continuing trend of profitable growth amidst global turmoil in the Life Sciences market. OpenQ posted a phenomenal 250% revenue growth in first quarter of 2009 compared to the same quarter last year. The exceptional first quarter results were driven primarily by new customer signings in the US and Europe. OpenQ is now serving 7 of the top 10 pharmaceutical and 3 of the top 5 medical device companies.
The results of the first quarter continue the trend of rapid growth enjoyed by the company in 2008 and expected for the rest of 2009.
"We are extremely pleased by these numbers and we believe that increasingly openQ products are becoming the critical components for life sciences companies in managing compliance, KOL relationships, speakers, and content. As we continue to expand our product portfolio and build strong partnerships with our customers, we are poised for strong growth in coming years.” said Jim Zuffoletti, openQ President.
"Our offerings bring to clients the best in class solutions for managing the growing challenges they are facing in the market. In the compliance space alone, openQ has introduced several innovative solutions and data products to meet the new market realities around supporting FMV, disclosure, aggregate spend, and spending caps. We have also continued our commitment to open standards and cloud computing through our products and the way we support customers." said Otavio Freire, openQ Executive Vice President Technology.
OpenQ product launches, led by openQ, also included new releases for:
-Real-Time Identification
-Presentation Management
-Compliance and Management of Educational Grants and Investigator Initiated Trials
-Organization Profiling and Analytics
Photo:
http://www.prlog.org/
